Hybrid IgE-IgG1 antibodies (IgEG): a new antibody class that combines IgE and IgG functionality
IgG-based anti-cancer therapies have achieved promising clinical outcomes, but, especially for patients with solid tumors, response rates vary. IgE antibodies promote distinct immune responses compared to IgG and have shown anti-tumoral pre-clinical activity and preliminary efficacy and safety profi...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Taylor & Francis Group
2025-12-01
|
| Ráidu: | mAbs |
| Fáttát: | |
| Liŋkkat: | https://www.tandfonline.com/doi/10.1080/19420862.2025.2502673 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|